Concepedia

Vittorio Silingardi

VS

Statistics

Publications

18

Citations

647

H-Index

14

Active since

1977

Affiliations

University of Modena and Reggio Emilia(Current)

University of Pavia

Istituti di Ricovero e Cura a Carattere Scientifico

Azienda Ospedaliero-Universitaria di Modena

Policlinico San Matteo Fondazione

Vittorio Silingardi is an author at University of Modena and Reggio Emilia specializing in medicine, oncology, and chemotherapy.

Publications per year

1977–2008

18

Publications

18

Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

Giampietro Gasparini, Massimo Gion, Luigi Mariani et al. · Breast Cancer Research and Treatment · 2006 · 138 citations · Full text

Medicine, Oncology, Pharmacology +17

LONG‐TERM EFFECTS OF PARENTERAL DICHLOROMETHYLENE BISPHOSPHONATE (CL2MBP) ON BONE DISEASE OF MYELOMA PATIENTS TREATED WITH CHEMOTHERAPY

Giampaolo Merlini, Giuseppe Attardo Parrinello, L Piccinini et al. · Hematological Oncology · 1990 · 68 citations

Medicine, Oncology, Pharmacotherapy +14

HODGKIN'S DISEASE PROGNOSIS: A DIRECTLY PREDICTIVE EQUATION

P. G. Gobbi, Massimo Federico, UbaldoA. Di Prisco et al. · The Lancet · 1988 · 63 citations · Full text

Medicine, Oncology, Pathology +9

Detection of Circulating Tumor Cells by Reverse Transcriptase Polymerase Chain Reaction of Maspin in Patients With Breast Cancer Undergoing Conventional-Dose Chemotherapy

Roberto Sabbatini, Massimo Federico, Monica Morselli et al. · Journal of Clinical Oncology · 2000 · 52 citations · Full text

Medicine, Oncology, Pathology +17

Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo

Bruna Fornarini, Consuelo D'Ambrosio, Clara Natoli et al. · Blood · 2000 · 44 citations

Medicine, Cancer Biology, Oncology +14

1–5 of 18